(–)-Epicatechin Supplementation Inhibits Aerobic Adaptations to Cycling Exercise in Humans

The purpose of the study was to determine if cycling exercise combined with (–)-epicatechin supplementation was more effective at increasing training adaptations than cycling combined with a placebo. Blood and muscle samples were obtained at rest before and after training to determine the effects of...

Full description

Bibliographic Details
Main Authors: Neil A. Schwarz, Zachary J. Blahnik, Srihari Prahadeeswaran, Sarah K. McKinley-Barnard, Shelley L. Holden, Andy Waldhelm
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-12-01
Series:Frontiers in Nutrition
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fnut.2018.00132/full
_version_ 1819212164089511936
author Neil A. Schwarz
Zachary J. Blahnik
Srihari Prahadeeswaran
Sarah K. McKinley-Barnard
Shelley L. Holden
Andy Waldhelm
author_facet Neil A. Schwarz
Zachary J. Blahnik
Srihari Prahadeeswaran
Sarah K. McKinley-Barnard
Shelley L. Holden
Andy Waldhelm
author_sort Neil A. Schwarz
collection DOAJ
description The purpose of the study was to determine if cycling exercise combined with (–)-epicatechin supplementation was more effective at increasing training adaptations than cycling combined with a placebo. Blood and muscle samples were obtained at rest before and after training to determine the effects of (–)-epicatechin supplementation on total serum antioxidant capacity, skeletal muscle mitochondrial protein content, and skeletal muscle myostatin gene expression. Participants (n = 20) completed two testing sessions separated by 4 weeks of cycle training, with supplementation of 100 mg (200 mg total daily) of (–)-epicatechin or a placebo, twice daily. Data were analyzed using a two-way mixed model ANOVA for each variable and the alpha level was set at p ≤ 0.05. A significant increase was observed for time for relative peak anaerobic power (p < 0.01), relative anaerobic capacity (p < 0.01), and fatigue index (p < 0.01). A significant increase was observed for time for absolute peak VO2 (p < 0.01) and peak power output obtained during the peak VO2 test (p < 0.01). A significant interaction between group and time for relative peak VO2 was observed (p = 0.04). Relative peak VO2 significantly increased over time in the placebo group (p < 0.01), but not in the (–)-epicatechin group (p = 0.21). A significant increase was observed for time for total serum antioxidant capacity (p = 0.01). No interaction or main effect of time was observed for myostatin (p > 0.05). Likewise, no interaction or main effect of time was observed for cytochrome C or citrate synthase (p > 0.05). A significant interaction effect was observed for succinate dehydrogenase (SDH; p = 0.02). SDH content increased significantly for the placebo group (p = 0.03, partial η2 = 0.59), but not for the (–)-epicatechin group (p = 0.81). Further, whereas no difference existed between the groups for SDH at baseline (p = 0.23), SDH content was significantly greater in the placebo group at the post time point (p = 0.01). Results indicate that (–)-epicatechin supplementation does not affect myostatin gene expression or anaerobic training adaptations but inhibits aerobic and mitochondrial SDH adaptations to cycle exercise training.
first_indexed 2024-12-23T06:38:36Z
format Article
id doaj.art-9de7e8f61d4b4bb5b8120a7aaab8d5f1
institution Directory Open Access Journal
issn 2296-861X
language English
last_indexed 2024-12-23T06:38:36Z
publishDate 2018-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Nutrition
spelling doaj.art-9de7e8f61d4b4bb5b8120a7aaab8d5f12022-12-21T17:56:43ZengFrontiers Media S.A.Frontiers in Nutrition2296-861X2018-12-01510.3389/fnut.2018.00132435003(–)-Epicatechin Supplementation Inhibits Aerobic Adaptations to Cycling Exercise in HumansNeil A. Schwarz0Zachary J. Blahnik1Srihari Prahadeeswaran2Sarah K. McKinley-Barnard3Shelley L. Holden4Andy Waldhelm5Department of Health, Kinesiology, and Sport, University of South Alabama, Mobile, AL, United StatesDepartment of Health, Kinesiology, and Sport, University of South Alabama, Mobile, AL, United StatesDepartment of Health, Kinesiology, and Sport, University of South Alabama, Mobile, AL, United StatesDepartment of Health, Kinesiology, and Sport, University of South Alabama, Mobile, AL, United StatesDepartment of Health, Kinesiology, and Sport, University of South Alabama, Mobile, AL, United StatesDepartment of Physical Therapy, University of South Alabama, Mobile, AL, United StatesThe purpose of the study was to determine if cycling exercise combined with (–)-epicatechin supplementation was more effective at increasing training adaptations than cycling combined with a placebo. Blood and muscle samples were obtained at rest before and after training to determine the effects of (–)-epicatechin supplementation on total serum antioxidant capacity, skeletal muscle mitochondrial protein content, and skeletal muscle myostatin gene expression. Participants (n = 20) completed two testing sessions separated by 4 weeks of cycle training, with supplementation of 100 mg (200 mg total daily) of (–)-epicatechin or a placebo, twice daily. Data were analyzed using a two-way mixed model ANOVA for each variable and the alpha level was set at p ≤ 0.05. A significant increase was observed for time for relative peak anaerobic power (p < 0.01), relative anaerobic capacity (p < 0.01), and fatigue index (p < 0.01). A significant increase was observed for time for absolute peak VO2 (p < 0.01) and peak power output obtained during the peak VO2 test (p < 0.01). A significant interaction between group and time for relative peak VO2 was observed (p = 0.04). Relative peak VO2 significantly increased over time in the placebo group (p < 0.01), but not in the (–)-epicatechin group (p = 0.21). A significant increase was observed for time for total serum antioxidant capacity (p = 0.01). No interaction or main effect of time was observed for myostatin (p > 0.05). Likewise, no interaction or main effect of time was observed for cytochrome C or citrate synthase (p > 0.05). A significant interaction effect was observed for succinate dehydrogenase (SDH; p = 0.02). SDH content increased significantly for the placebo group (p = 0.03, partial η2 = 0.59), but not for the (–)-epicatechin group (p = 0.81). Further, whereas no difference existed between the groups for SDH at baseline (p = 0.23), SDH content was significantly greater in the placebo group at the post time point (p = 0.01). Results indicate that (–)-epicatechin supplementation does not affect myostatin gene expression or anaerobic training adaptations but inhibits aerobic and mitochondrial SDH adaptations to cycle exercise training.https://www.frontiersin.org/article/10.3389/fnut.2018.00132/fullmyostatinsuccinate dehydrogenaseoxygen consumption (VO2)polyphenolsflavanolscocoa extract
spellingShingle Neil A. Schwarz
Zachary J. Blahnik
Srihari Prahadeeswaran
Sarah K. McKinley-Barnard
Shelley L. Holden
Andy Waldhelm
(–)-Epicatechin Supplementation Inhibits Aerobic Adaptations to Cycling Exercise in Humans
Frontiers in Nutrition
myostatin
succinate dehydrogenase
oxygen consumption (VO2)
polyphenols
flavanols
cocoa extract
title (–)-Epicatechin Supplementation Inhibits Aerobic Adaptations to Cycling Exercise in Humans
title_full (–)-Epicatechin Supplementation Inhibits Aerobic Adaptations to Cycling Exercise in Humans
title_fullStr (–)-Epicatechin Supplementation Inhibits Aerobic Adaptations to Cycling Exercise in Humans
title_full_unstemmed (–)-Epicatechin Supplementation Inhibits Aerobic Adaptations to Cycling Exercise in Humans
title_short (–)-Epicatechin Supplementation Inhibits Aerobic Adaptations to Cycling Exercise in Humans
title_sort epicatechin supplementation inhibits aerobic adaptations to cycling exercise in humans
topic myostatin
succinate dehydrogenase
oxygen consumption (VO2)
polyphenols
flavanols
cocoa extract
url https://www.frontiersin.org/article/10.3389/fnut.2018.00132/full
work_keys_str_mv AT neilaschwarz epicatechinsupplementationinhibitsaerobicadaptationstocyclingexerciseinhumans
AT zacharyjblahnik epicatechinsupplementationinhibitsaerobicadaptationstocyclingexerciseinhumans
AT srihariprahadeeswaran epicatechinsupplementationinhibitsaerobicadaptationstocyclingexerciseinhumans
AT sarahkmckinleybarnard epicatechinsupplementationinhibitsaerobicadaptationstocyclingexerciseinhumans
AT shelleylholden epicatechinsupplementationinhibitsaerobicadaptationstocyclingexerciseinhumans
AT andywaldhelm epicatechinsupplementationinhibitsaerobicadaptationstocyclingexerciseinhumans